![Nora Frey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nora Frey
Director/Miembro de la Junta en Citryll BV .
Cargos activos de Nora Frey
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Director/Miembro de la Junta | - | - |
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Director/Miembro de la Junta | 13/10/2021 | - |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Inversor de Capital Privado | 01/03/2019 | - |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Director/Miembro de la Junta | - | - |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Consultor / Asesor | 01/01/2009 | - |
Historial de carrera de Nora Frey
Antiguos cargos conocidos de Nora Frey.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Octa Phillip Bioscience Advisory Pty Ltd.
![]() Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Presidente | 03/06/2011 | - |
Miembro del Comité de Inversión | - | - | |
Inversor de Capital Privado | 03/06/2011 | - | |
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Director de Inversiones | 01/12/2000 | - |
Director de Investigación - Acciones | 01/12/2000 | - | |
Gestor de Cartera-Acciones | 01/12/2000 | - | |
Presidente | 01/12/2000 | - |
Formación de Nora Frey.
University of Basel | Doctorate Degree |
Estadísticas
Internacional
Suiza | 3 |
Francia | 3 |
Reino Unido | 2 |
Operativa
Director/Board Member | 3 |
Private Equity Investor | 2 |
Chief Investment Officer | 1 |
Sectorial
Finance | 5 |
Health Technology | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Octa Phillip Bioscience Advisory Pty Ltd.
![]() Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Finance |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Commercial Services |
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Health Technology |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Health Technology |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Finance |
- Bolsa de valores
- Insiders
- Nora Frey
- Experiencia